Outcomes of 1000 Carotid Wallstent Implantations

2016 ◽  
Vol 23 (2) ◽  
pp. 267-274 ◽  
Author(s):  
Sonia Ronchey ◽  
Barbara Praquin ◽  
Matteo Orrico ◽  
Eugenia Serrao ◽  
Cristina Ciceroni ◽  
...  
Keyword(s):  
Carotid Wallstent

scholarly journals Endovascular treatment of the vertebral artery origin stenosis by using the closed-cell, self-expandable Carotid Wallstent

2020 ◽  
Vol 26 (6) ◽  
pp. 805-813
Author(s):  
Jun-Kyeung Ko ◽  
Chang-Hwa Choi ◽  
Lee Hwangbo ◽  
Hie-Bum Suh ◽  
Tae-Hong Lee ◽  
...  
Keyword(s):  
Endovascular Treatment ◽  
Vertebral Artery ◽  
Good Alternative ◽  
Minor Stroke ◽  
Stent Restenosis ◽  
Vertebrobasilar Ischemia ◽  
Closed Cell ◽  
Carotid Wallstent ◽  
Permanent Neurological Deficit

Background Endovascular treatment has been considered a good alternative to surgery for symptomatic vertebral artery origin stenosis (VAOS) due to the high risk of morbidity associated with surgery. The purpose of this study was to evaluate the feasibility and efficacy of insertion of the closed-cell, self-expandable Carotid Wallstent for the treatment of VAOS. Methods The records of 72 patients with VAOS refractory to adequate medication who were treated by endovascular treatment with the Carotid Wallstent from December 2006 to November 2018 were retrospectively evaluated. Results Of the 72 patients, 43 presented with transient ischemic attacks. Forty-seven patients (65.3%) manifested other brachiocephalic stenoses; of these, 40 patients had occlusion, hypoplasia, or stenosis of the contralateral vertebral artery. Overall technical success (defined as 20% or less residual stenosis) was 100%. Procedure-related complications ( n = 8, 11.1%) included sudden asystole ( n = 1), acute in-stent thrombosis ( n = 3), minor stroke ( n = 3), and stent shortening ( n = 1). All complications were resolved without permanent neurological deficit. Angiographic follow-up (mean, 13.0 months) was achieved in 49 patients and revealed in-stent restenosis in 1 patient (2.0%) and stent malposition by shortening in 2 patients (4.1%). Follow-up records were available in 57 patients (mean 15.6 months). Three of the 57 patients ( n = 3, 5.3%) had recurrent symptoms of vertebrobasilar ischemia and none was retreated. Conclusions Endovascular treatment of symptomatic VAOS using the closed-cell, self-expandable Carotid Wallstent is technically feasible and effective in alleviating patient symptoms and for improving vertebrobasilar blood flow.

scholarly journals Imaging Follow-up after Carotid Artery Stenting with Carotid Wallstent Using Computed Tomographic Angiography

2017 ◽  
Vol 45 (1) ◽  
pp. 7-13
Author(s):  
Tatsufumi NOMURA ◽  
Daisuke SASAMORI ◽  
Tadashi NONAKA ◽  
Akira TAKAHASHI ◽  
Yasuyuki YONEMASU ◽  
...  
Keyword(s):  
Carotid Artery ◽  
Carotid Artery Stenting ◽  
Computed Tomographic Angiography ◽  
Computed Tomographic ◽  
Tomographic Angiography ◽  
Carotid Wallstent

scholarly journals Delayed carotid wallstent shortening

2015 ◽  
Vol 8 ◽  
pp. 68-70
Author(s):  
L. Garriboli ◽  
A.M. Jannello
Keyword(s):  
Carotid Wallstent

Initial experience of carotid artery stenting using the Carotid WALLSTENT and FilterWire EZ in Japan

2011 ◽  
Vol 29 (1) ◽  
pp. 51-58 ◽  
Author(s):  
Katsutoshi Takayama ◽  
Toshiaki Taoka ◽  
Hiroyuki Nakagawa ◽  
Kaoru Myouchin ◽  
Takeshi Wada ◽  
...  
Keyword(s):  
Carotid Artery ◽  
Carotid Artery Stenting ◽  
Initial Experience ◽  
Carotid Wallstent

Carotid Artery Stenting with Distal Protection Using the Carotid Wallstent and Filterwire Neuroprotection: Single-Center Experience of 380 Cases with Midterm Outcomes

Vascular ◽  
2006 ◽  
Vol 14 (5) ◽  
pp. 237-244 ◽  
Author(s):  
Peter H. Lin ◽  
Wei Zhou ◽  
Marlon A. Guerrero ◽  
Sally A. McCoy ◽  
Deborah Felkai ◽  
...  
Keyword(s):  
High Risk ◽  
Carotid Artery ◽  
Stent Placement ◽  
Carotid Artery Stenting ◽  
Multivariable Analysis ◽  
Related Complication ◽  
Asymptomatic Patients ◽  
Distal Protection ◽  
Carotid Wallstent

Emerging data have supported the clinical efficacy of carotid artery stenting (CAS) in stroke prevention in high-risk surgical patients. This study was performed to evaluate the midterm clinical outcome of CAS using the Carotid Wallstent and FilterWire distal protection (both Boston Scientific, Natick, MA) at an academic institution. Risk factors for in-stent restenosis (ISR) were also analyzed. Clinical variables and treatment outcome of high-risk patients who underwent Carotid Wallstent placement with FilterWire EX/EZ neuroprotection were analyzed during a recent 54-month period. Three hundred eighty CAS procedures were performed in 354 patients. Technical success was achieved in 372 cases (98%), and symptomatic lesions existed in 85 (24%) patients. No patient experienced periprocedural mortality or neuroprotective device–related complication. The 30-day stroke and death rate was 2.7%, and the overall complication rate was 6.9%. The overall major or fatal stroke rates in symptomatic and asymptomatic patients were 4.6% and 1.3%, respectively (not significant). The overall stroke and death rates between the symptomatic and asymptomatic groups were 5.8% and 2.4%, respectively (not significant). The median follow-up period was 29 months (range 1–53 months). With Kaplan-Meier analysis, the rates of freedom from 60% or greater ISR after CAS procedures at 12, 24, 36, and 48 months were 97%, 94%, 92%, and 90%, respectively. The rates of freedom from all fatal and nonfatal strokes at 12, 24, 36, and 48 months were 97%, 91%, 89%, and 85%, respectively. Multivariable analysis of significant univariate predictors identified that postendarterectomy stenosis (odds ratio [OR] 3.98, p = .02) and multiple stent placement (OR 3.68, p = .03) were independent predictors of ISR. Our study yielded favorable short-term and midterm clinical results using Carotid Wallstent with FilterWire neuroprotection. Late follow-up results showed low rates of fatal and nonfatal stroke and favorable ISR rates compared with other carotid stent trials. Postendarterectomy and multiple stent placement were associated with subsequent ISR.

scholarly journals 262 An attractive endovascular strategy for combined—aneurysmal and stenotic—coronary artery disease

2021 ◽  
Vol 23 (Supplement_G) ◽  
Author(s):  
Fauzia Vendrametto ◽  
Alessandro Pierri ◽  
Davide Barbisan ◽  
Rita Piazza ◽  
Daniela Pavan ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Multidisciplinary Approach ◽  
Revascularization Procedure ◽  
Artery Disease ◽  
The Right ◽  
Adjacent Segments ◽  
Carotid Wallstent ◽  
Stenotic Lesions ◽  
Vessel Coronary Artery

Abstract In patients undergoing coronary angiography the coexistence of aneurysmal and stenotic lesions in adjacent segments of the same epicardial vessel is uncommon. We describe a rare case of single-vessel coronary artery disease (CAD) in a 70-year-old male, presenting with progressive effort-induced angina of 3-months’ evolution. The coronary angiogram revealed a critical calcified stenosis in the context of diffuse ectasia affecting the right coronary artery (RCA). Our report focuses on a complex revascularization procedure using the self-expandable Carotid Wallstent. Highlighting the importance of a multidisciplinary approach, we provide an original and effective endovascular solution for an unusual pathological angiographic finding, which could be of potential interest for interventional cardiologists.

Sign in / Sign up

Export Citation Format

Share Document